Member Info for Tra1

remember this chart, said before a daily close above .07 (yesterday) will make it accelerate, here we go, __ https://invst.ly/sjbof

* auto correction, multibag -:)

this investment in its own is enough to multi-age vela but we still have cash and more investments to come!
”..shareholders are in for a 'lively' time in the coming weeks and months..."

still cheap, below the placing price, once this meds. adopted by the nhs for covid patients and gets FDA approval for this use, remember this trial is also funded by the UK government

Good morning,
been researching the new investment, sounds great__ "David Tapolczay, CEO St George Street, said: “Given the current crisis, we have paused all our current research programmes to focus totally on this clinical trial and evaluate this potentially life-saving new drug...."
https://www.drwf.org.uk/news-and-events/news/trials-begin-new-treatment-could-help-people-living-type-1-diabetes-diagnosed

i am happy with the way it is moving, steady re rate

-:) the thing is everyone (including me) has come across a mutibagger and most have missed it just because they keep jumping from one share to another for a 10-20%, ncyt come to mind, well here is another chance hold and enjoy the ride.

yep, also remember these meds to treat the complications (DM, res etc) will be more important longer term than ”the vaccine”

The drug will be trialled on coronavirus patients in UK hospitals who have 'mild to moderate' symptoms.
If it works the company suggested the drug could be prescribed by a GP to diabetic people who have early symptoms of Covid-19.

already started, should not take long for the trial to complete__https://www.dailymail.co.uk/news/article-8661631/Doctors-trial-treatment-Covid-19-patients-diabetes.html

.75 is the support now 200ma should start re rating from here

*probably

it is poly one of the easiest phase II trials as the drug has already shown good outcome in diabetic patients, only to prove the same outcome in covid pts

AstraZeneca will supply the drug substance and St George Street will lead the clinical trial, enrolling 150 patients in hospitals in the UK over a 3-month timeframe.

St George Street is delighted to announce they have recently received approval from the MHRA for the ARCADIA clinical trial. A vastly accelerated timescale driven by the urgency of the current pandemic. The initiation of this clinical trial forms part of an existing collaboration with AstraZeneca as part of its Open Innovation programme

some info__ https://www.sgscapital.org

expect a ceo interview later today or 2moro to expand more on the new deal

i remember mph doubled their sp same day of a similar rns (was not covid) and never retraced. Just remember the likes of Professor Sir Christopher Evans, Mubadala - the UAE sovereign wealth fund) only invest in multibaggers

lovely, well done JN, multibagger in the making. short term, should move and stay above .11 ish

oh, did not notice, was in the middle of other things, but it seems the chunky sell yesterday was the last of the warrants, every small buy now is lifting the sp.